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Background: Schizophrenia is a severe psychiatric disorder with a high heritability. A single nucleotide polymorphism (SNP) rs1625579 (G/T; T
is the common and presumed risk allele) within an intron of miR-137 gene has been recently suggested to contribute to the susceptibility to
schizophrenia by a large-scale genome-wide association study (GWAS) in a sample of predominantly European ancestry. However, subsequent
genetic association studies in Chinese population yielded inconsistent results.
Methods: A meta-analysis reporting the association between rs1625579 and schizophrenia in Chinese population was carried out, pooling 4
eligible case–control studies involving 2847 patients and 3018 controls.
Results: Thismeta-analysis demonstrated a significant association between rs1625579 and schizophrenia under the allelemodel [T versus G, odds
ratio (OR):1.20, 95% confidence interval (CI): 1.06–1.36] and the recessive model (TT versus GT + GG; OR: 1.19; 95% CI: 1.04–1.37).
Additionally, a marginal significant association under the additive model (TT versus GG; OR: 1.64; 95%CI: 1.00–2.69) was observed. However,
no significant association was observed under the dominant model (TT + GT versus GG; OR: 1.58; 95% CI: 0.97–2.59).
Conclusions: This meta-analysis suggested that the SNP rs1625579 in miR-137 gene might be involved in schizophrenia susceptibility in
Chinese Han population.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CCBY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Schizophrenia is a disabling psychiatric disorder that affects
approximately 1% of the worldwide population [1]. It has been
proved that schizophrenia has a high heritability of approxi-
mately 64% [2] and involves multiple candidate genes [3].
However the exact etiology and genetic mechanisms ofAbbreviations: miRNAs, microRNAs; GWAS, genome-wide associ-
ation study; SNP, single nucleotide polymorphism; GSEA, gene set
enrichment analysis; PRISMA, Preferred Reporting Items for Systematic
Reviews and Meta-Analysis; DSM-IV, Diagnosis and Statistical Manual of
Mental Health Disorders, Fourth Edition; ICD-10, the International
Classification of Diseases 10; OR, odds ratio; 95% CI, 95% confidence
interval; NOS, Newcastle–Ottawa Scale; HWE, Hardy–Weinberg equilib-
rium; M-H, Mantel–Haenszel method; BD, bipolar disorder.
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licenses/by-nc-nd/4.0/).schizophrenia are still unknown, as the brain dysfunction of
schizophrenia patients is caused by the accumulation of
dysregulation events in susceptibility genes [4]. MicroRNAs
(miRNAs) are critical to neurodevelopment and adult neuronal
processes by modulating the activity of multiple genes as
“pathway” or “network regulators” [5]. This is particularly
intriguing for highly polygenic diseases like schizophrenia.
Till now many miRNAs have been found to be differentially
expressed in blood samples [6,7] or postmortem brain
tissue samples [8–11] of schizophrenia patients, which provided
strong evidences that miRNAs may affect the disorder.
Among them, miR-137 was identified to be a candidate
gene for schizophrenia susceptibility by a recent large-scale
genome-wide association study (GWAS) predominantly in
European ancestry, in which the single nucleotide polymor-
phism (SNP) rs1625579 (G/T; T is the common and presumed
risk allele) within an intron of miR-137 gene had the strongest
genetic association with schizophrenia [12]. MiR-137 was first
identified as a risk factor for schizophrenia in a gene set
enrichment analysis (GSEA) in 2010 [13]. After that, manyess article under the CC BY-NC-ND license (http://creativecommons.org/
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latest GWAS in 2014 also found significant heterogeneity for
the rs1625579 polymorphismofmiR-137 in schizophrenia [14–
19]. Despite the evidence of strong association in Caucasians,
consistent results were not obtained whether this SNP is
associated with schizophrenia in Chinese population [20–23].
Ma [21] performed a meta-analysis combining five studies
which were based on several different ethnicities and their own
study based on Southern Han Chinese. Yuan [23] conducted a
meta-analysis based on three Han Chinese studies; however the
study involved only one geneticmodel.We therefore conducted
a meta-analysis integrating four Chinese case–control studies
under four different geneticmodels to evaluate the association of
rs1625579 in miR-137 gene with schizophrenia in Chinese.
2. Methods
2.1. Literature search
PubMed, EMBASE and Cochrane Library were indepen-
dently searched by two reviewers (Ping Zhang andYi Bian) for
potentially eligible studies from the earliest available date to
June 2015, using the combination of the keywords “schizo-
phrenia”, “miR-137”, “miR137”, “microRNA-137” and
“microRNA137”. References of reviews and retrieved articles
were also manually searched for studies meeting our criteria.
Abstracts identified using those strategies were reviewed
respectively by two reviewers (Ping Zhang and Yi Bian).
Then the full-texts of potentially eligible studies were reviewed
in duplicate to determine the inclusion in the meta-analysis. We
conducted the meta-analysis and reported the results according
to the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) statement.
2.2. Inclusion criteria
Eligible studies in this meta-analysis must meet the
following criteria: (1) case–control study or large-scale
replication study assessing the association between SNP
rs1625579 in miR-137 gene and schizophrenia as an original
study; (2) involving subjects restricted to Chinese ethnicity;
(3) schizophrenia cases being diagnosed according to
DSM-IV or ICD-10 criterion, with control subjects having
no history of mental disorder, other neurological disease,
drug addiction or alcohol addiction; (4) providing sufficient
data for calculating genotypic odds ratio (OR) with 95%
confidence interval (95% CI); (5) samples having no overlap
with the other identified studies. The quality of studies was
assessed with the Newcastle–Ottawa Scale (NOS) (http://
www.ohri.ca/programs/clinical_epidemiology/oxford.asp)
for observational studies.
2.3. Data extraction
Data extraction was performed independently by two
reviewers (Ping Zhang and Yi Bian) who reached a
consensus on all of the items. For each eligible study, the
following data were extracted: first author's name, year ofpublication, ethnicity and geographic location of the studied
population, definition of cases, genotyping method, male
percentage and mean ages in case and control groups, sample
size of case and control groups, genotype distributions.
2.4. Statistical analysis
Hardy–Weinberg equilibrium (HWE) was assessed for each
study by goodness-of-fit X2 test (PN0.05) only in control
groups. Meta-analysis was conducted using Review Manager
5.3 (http://tech.cochrane.org/revman/download) and a probabil-
ity value of Pb0.05 was considered statistically significant.
Pooled effect was calculated for the allele model (T versus G),
recessive model (TT versus GT + GG), dominant model
(TT + GT versus GG) and additive model (TT versus GG)
respectively. Heterogeneity among studies was assessed using
Q test and was considered significant when P b 0.05. Then
heterogeneity was qualified by Higgins I2: I2 = 0–25%, no
heterogeneity; I2 = 25–50%,moderate heterogeneity; I2 = 50–
75%, large heterogeneity; I2 = 75–100%, extreme heterogene-
ity. A fixed-effect model (Mantel–Haenszel method, M-H) was
applied when there was no obvious heterogeneity; otherwise a
random-effects model was Adopted. Funnel plot and Egger's
test were applied to evaluate the evidence for publication bias.
Sensitivity analysis was conducted to assess the influence of
each study on overall pooled result by sequentially excluding
each individual study.3. Results
3.1. Study inclusion and characteristics
A flow chart of the literature search and selection process
is detailed in Fig. 1. A comprehensive search identified 101
references. After removing the duplicate literature, a total of
90 publications were screened. After review of abstracts 71
were rejected, leaving 19 potentially eligible studies. The full
texts of the 19 literatures were screened to examine their
eligibility based on the inclusion criteria. Among them, 15
studies were excluded (7 didn't report Chinese population; 3
were reviews or editorial comments; 5 didn't focus on
rs1625579). Thus 4 studies [20–23] were considered eligible
for the present meta-analysis.
The characteristics of the four included studies are listed in
Table 1. All of the included studies were based on Chinese Han
population but from different areas (one from north China, one
from south China, one from east China and one from central
China). In total the study included 2847 schizophrenia cases and
3018 healthy controls. The distributions of alleles and genotypes
in individual studies are detailed in Table 2. None of the
genotype distributions in each control group significantly
deviated from HWE.
3.2. Results of overall meta-analysis
Fig. 2 summarizes the ORs with corresponding 95% CIs
for the association between rs1625579 polymorphism in
Fig. 1. Flow diagram of the literature search and selection.
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genetic models. For the studies of binary outcomes, allele
model (T versus G) was tested. For the analyses of
continuous outcomes, recessive model (TT versus
GT + GG), dominant model (TT + GT versus GG) and
additive model (TT versus GG) were tested. A fixed-effect
model (M-H) was applied to all the models according to the
P values for heterogeneity. The meta-analysis of the four
selected studies provided an OR of 1.20 (95% CI, 1.06–1.36;
P Heterogeneity, 0.15) under the allele model (T versus G),
which suggested that the “T” allele of SNP rs1625579 withinmiR-137 is significantly associated with schizophrenia risk
in Chinese Han population. A significant association under
the recessive model (TT versus GT + GG; OR, 1.19; 95%
CI, 1.04–1.37; P Heterogeneity, 0.23) and a marginal
significant association under the additive model (TT versus
GG; OR, 1.64; 95% CI, 1.00–2.69; P Heterogeneity, 0.33)
were observed by pooling the four selected studies.
However, no significant association was observed under the
dominant model (TT + GT versus GG; OR, 1.58; 95% CI,
0.97–2.59; P Heterogeneity, 0.34). The main meta-analysis
results are listed in Table 3.
Table 1
The characteristics of the studies included in the meta-analysis for the association of rs1625579 with schizophrenia in Chinese population.
First
Author,
Published
Year
Ethnicity Sample
Area
Schizophrenia Cases Healthy Controls Definition of
Schizophrenia
Genotyping
Method
N Mean Age Gender
(% Male)
N Mean Age Gender
(% Male)
Guan, 2014 Chinese Han Shaanxi 1430 Male 37.6 ± 11.2,
Female 35.1 ± 10.6
53.4 1570 Male 32.9 ± 10.9,
Female 34.2 ± 11.7
54.8 DSM-IV Mass ARRAY
Ma, 2014 Chinese Han Guangdong 611 35.6 ± 14.0 65.0 628 36.5 ± 12.1 66.4 DSM-IV SNaPshot
Wang, 2014 Chinese Han Henan 300 31.7 ± 9.6 50.0 300 31.5 ± 8.9 50.0 DSM-IV NA
Yuan, 2014 Chinese Han Jiangsu 506 47.2 ± 11.2 55.3 520 45.4 ± 8.9 51.5 DSM-IV LDR–PCR
DSM-IV, diagnosis and statistical manual of mental health disorders, fourth edition; NA, not available from the published study; LDR–PCR, ligase detection
reaction–polymerase chain reaction.
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As no severe heterogeneity was observed and eligible
studies were limited, sensitivity analysis was not performed.
3.4. Publication bias
The funnel plots and the Egger's tests demonstrated that
there was no significant publication bias in the allele model
and the recessive model with P for Egger's test N0.05 (Fig. 3,
Table 3). The P value for Egger's test under the dominant
model and the additive model could not be calculated because
the frequency of genotype “GG” in some studies was 0.4. Discussion
Recently, a study by the Schizophrenia Psychiatric GWAS
Consortium with 17,836 European schizophrenia cases and
33,859 controls reported genome-wide significant associations
of SNP rs1625579 in a gene, which encodes for miR-137, with
schizophrenia [12]. The latest GWAS in 2014 conducted by
the Schizophrenia Working Group of the Psychiatric Geno-
mics Consortium confirmed the result [19]. In addition, four of
the putative targets (CSMD1, C10orf26, CACNA1C and
TCF4) of miR-137 also achieved genome-wide significance.
Furthermore, another well-replicated schizophrenia candidate
gene (ZNF804A) has been recently shown to be a miR-137
target [24]. These data strongly indicated that rs1625579 is a
promising risk SNP for schizophrenia in European popula-
tions, but the association is less clear among other populations,Table 2
Distributions of alleles and genotypes in individual studies.
First
Author,
Published
Year
Allele
Schizophrenia Control S
T G T G TT
Guan, 2014 2520 340 2694 446 1111
Ma, 2014 1159 63 1164 92 550
Wang, 2014 569 31 565 35 269
Yuan, 2014 949 63 986 54 445
HWE, Hardy–Weinberg equilibrium.including Han Chinese. In our study, we observed statistical
evidence for a significant association of SNP rs1625579within
miR-137 gene with schizophrenia in Chinese Han population
under three genetic models, which suggested that the “T” allele
and “TT” genotype of rs1625579 are risk factors of
schizophrenia. This finding is consistent with European
GWAS results [12,19]. Before our study, Ma [21] also found
an association between rs1625579 and schizophrenia, but did
not focus on Chinese Han population. Another researcher
Yuan [23] drew a negative conclusion on the association
between rs1625579 and schizophrenia in Han Chinese.
After the large-scaled 2011 GWAS study [12], several
studies examined the association between rs1625579 and
quantitative phenotypes in different populations [14–18].
For example, Whalley [14] examined the “TT” risk genotype
subjects from Scotland at SNP rs1625579 and observed
neuropsychological deficits which were commonly observed
in schizophrenia and bipolar disorder (BD) patients.
Moreover, reduced activation of the right posterior medial
frontal gyrus and increased activation of the left amygdala
and pre/postcentral gyrus were observed in “TT” risk
genotype group during a sentence completion task, suggest-
ing a more schizophrenia effect of the “T” risk allele. Green
[15] found in Australians the association of risk alleles on the
rs1625579 SNP with a schizophrenia subtype characterized
by severe cognitive impairment and negative symptoms. Lett
[16] reported that rs1625579 risk genotype strongly
predicted a schizophrenia sub-phenotype with earlier
age-at-onset and compromised brain structure in Canadian
and American patients. However, studies in Chinese HanGenotype HWE
p-Value
for
Controls
chizophrenia Control
GT GG TT GT GG
298 21 1162 370 38 0.212
59 2 541 82 5 0.338
31 0 265 35 0 0.283
59 2 466 54 0 0.212
Fig. 2. Meta-analysis for the association of rs1625579 with schizophrenia in Chinese population. A. Allele model: T versus G; B. Recessive model: TT versus
GT + GG; C. Dominant model: TT + GT versus GG; D. Additive model: TT versus GG. M-H, Mantel–Haenszel method; 95% CI, 95% confidence interval.
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in Shaanxi Province and Ma's study [21] in Guangdong
Province achieved consistent conclusion with European
GWAS, while Wang's study [22] in Henan Province and
Yuan's study [23] in Jiangsu Province found no relationship
between rs1625579 and schizophrenia. Attention should be
paid to the differences of genetic frequencies among thosestudies. The “G” allele frequencies of SNP rs1625579 in
healthy controls from Guan's, Ma's, Wang's and Yuan's
studies were 14.20% [20], 7.32% [21], 5.83% [22] and
5.19% [23], respectively. And the “GG” genotype frequen-
cies in healthy controls from the four Chinese studies were
2.42% [20], 0.80% [21], 0 [22] and 0 [23], which suggested
that genetic heterogeneity might exist among Chinese
Table 3
Meta-analysis for the association of rs1625579 with schizophrenia in Chinese population.
Genetic Model OR 95% CI P P Heterogeneity I2 P for Egger's test
Allele model: T versus G 1.20 (1.06, 1.36) 0.005 0.15 43% 0.052
Recessive model: TT versus GT + GG 1.19 (1.04, 1.37) 0.01 0.23 31% 0.092
Dominant model: TT + GT versus GG 1.58 (0.97, 2.59) 0.07 0.34 6% -
Additive model: TT versus GG 1.64 (1.00, 2.69) 0.05 0.33 10% -
OR, odds ratio; 95% CI, 95% confidence interval.
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much more significant differences of genetic frequencies
between Chinese and other Ethnicities were presented. The
“G” allele and “GG” genotype frequencies were 20.37% and
2.47% in healthy Scottish controls [14], 20.88% and 4.27% in
Australians [15], and 20.66% and 4.13% in Canadians and
Americans [16]. Therefore, more researches with large sample
size and multi sample source will be necessary for drawing a
conclusion in Chinese Han population. During literature
searching, we found twoGWASs in 2011 focusing on the gene
risk of schizophrenia in Han Chinese [25,26]. However, no
data concerning rs1625579 were found in both studies.Fig. 3. Funnel plots for the publication bias. A. Allele model: T versus G; B. Reces
D. Additive model: TT versus GG. OR, odds ratio.The data presented in our meta-analysis are limited;
therefore caution should be paid during interpreting results
and making conclusions. Firstly, inclusion of retrospective
observational studies which were based on case–control
design inevitably introduced a source of potential selection
bias and measurement bias which exist in non-randomized,
unblinded design. Secondly, the number of eligible studies
and the total sample size were not large enough to obtain a
precise assessment between SNP rs1625579 and schizo-
phrenia in whole Chinese population. Additionally, though
not significantly, mild heterogeneity still existed among
included studies.sive model: TT versus GT + GG; C. Dominant model: TT + GT versus GG;
32 P. Zhang et al. / Comprehensive Psychiatry 67 (2016) 26–325. Conclusions
Collectively, our meta-analysis suggested that the SNP
rs1625579 in miR-137 gene might be involved in schizo-
phrenia susceptibility in Chinese Han population. Large
scale and multi-center studies in China for this association
are expected to be performed in near future.References
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